Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like 3 Biopharma Stocks Billionaire Money Managers Unloaded Recently May 23, 2017 Get Ready for the M&A Explosion January 30, 2018 Johnson & Johnson Yanks Plans for First R&D Facility in the UK November 27, 2017
